A comparative trial of digoxin and digitoxin in the treatment of congestive heart failure.
A randomized, crossover, single-blind study compared the efficacy and dosing accuracy of digoxin and digitoxin in 15 ambulatory patients wth congestive heart failure. Loading doses and maintenance doses were calculated according to published equations that adjust for sex, height, and lean body weight (for digitoxin), plus estimated creatinine clearance (for digoxin). At each 2-week visit, serum drug concentrations were measured and compliance with the prescribed regimen was assessed by tablet count. At the end of each study period, a congestive heart failure (CHF) score was determined in a blinded fashion by the same physician. Patient compliance was unusually high (greater than or equal to 80%) at every visit. Therapeutic concentrations were achieved with digoxin and digitoxin in 5 and 14 patients, respectively (p less than 0.05). During digitoxin therapy, CHF scores were lower than pretreatment values (p less than 0.05). The difference between CHF scores during the digoxin and digitoxin periods did not achieve significance (0.05 less than p less than 0.06). Therapeutic serum concentrations can be achieved more easily and frequently with digitoxin than digoxin without compromising the patient's CHF status.
Bussey
H I
HI
Department of Pharmacology, University of Texas Health Science Center, San Antonio 78284-7765.
Hawkins
D W
DW
Gaspard
J J
JJ
Walsh
R A
RA
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004074:Digitoxin / Q000097:blood / Q000627:therapeutic use*; D004077:Digoxin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation
D004077:Digoxin; D004074:Digitoxin